PLC, and our London based Partner Sirius Regulatory Consulting, today announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation to Jennerex’s product JX-594 for the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer. JX-594 is a novel Oncolytic Virus based on genetic modifications to a Vaccinia virus strain.
Pacific-Link Consulting today announced the establishment of Pacific-Link Consulting KK (PLC-KK), an affiliated kabushiki kaisha based in Tokyo, Japan. The Board of Directors of PLC-KK have appointed Sarina Tanimoto, MD PhD MBA as the Managing Director for the newly formed company in Tokyo. Dr. Tanimoto will manage the Japanese based business and brings more than
Pacific-Link Consulting (PLC) is proud to announce that the Japan External Trade Organization (JETRO) has appointed Richard Lowenthal MS MBA, President of PLC, as the “JETRO Investment in Japan Advisor for North America” for Medical products. PLC will advise JETRO in their evaluation of key medical technologies in the Pharmaceutical, Biotechnology and Medical Device industries